Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,497

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,881

Class I recallsReasonable probability of serious health consequences

24,543

Class II recallsTemporary or medically reversible health consequences

2,935

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,098 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-all-cheddar-cheese-products-because-possible-health-riskPublished November 10, 2026

Most affected stateHawaii 200 recalls mention this state

Advertisement

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 11, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIPO B CYANO 1MG/ML W/PRES. (BENZYL ETOH 1%) METHIONINE 25MG, INOSITOL 50MG, CHOLINE CHL-50MG, CYANO B-12-100MCG, BENZYL ALCOHOL 1%/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIPO-INJECTION W/LIDOCAINE (PF), ASCORBIC ACID 50MG; B1-50MG; B2-5-PO4-5MG; B3-50MG B5-5MG, B6-5MG, CYANO B-12-100MCG, METHIONINE 12.5 MG, INOSITOL 25 MG, CHOLINE CL-25 MG, LIDCAINE 10 MG/ML, 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-PHENYLALANINE 15MG/ML (PF), 50ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-CARNITINE 50MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

L-CARNITINE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYDROXY B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01%), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYDROGEN PEROXIDE 3% (PF), 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

GERMANIUM SESO 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2017Historical recordClass II

GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason: Lack of Assurance of Sterility
Published: July 20, 2016
Distribution: Nationwide

View recall →

Data last updated: November 11, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.